2. “Treat-Close-Treat” strategy in adult congenital heart disease related pulmonary arterial hypertension (ACHD-PAH)
International Journal of Cardiology Congenital Heart Disease · 2021
DOI: 10.1016/j.ijcchd.2020.100030 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cardiology Congenital Heart Disease, 2021. Verfasst von Yuan He und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
PA with VSD is a complex congenital cyanotic heart disease, with a wide range of anatomical and clinical variations.There is a significant population of babies born with this condition surviving into adulthood with extremely variable quality of life.High mortality in this population remains a concern for cardiologists.A lack of information in literature about the causes of death in this cohort prompted us to perform this study.
Methods
Retrospective case series and data were analysed from one of the largest regional databases in the country.Patients included were those with PA, VSDs and MAPCAs (n¼45).Patients with an intact septum, or TOF etc were excluded.
Results
In our cohort of patients with PA/VSD/MAPCAs 44.4% had died (n¼20).Of these causes of death were available for 50%.The demographics of this subset were -60% male and 40% female.Mean age was 39.3 years and median was 35.5 years.It was found that 60% of the patients died from end stage heart failure (n¼6).10% of patients (n¼1) died of arrhythmias.10% (n¼1) died of acute left ventricular failure.10% (n¼1) died of pulmonary artery stent erosion.10% (n¼1) died of possible aortic dissection.None of the patients had an ICD in-situ.
Conclusion
End stage heart failure remains the leading cause of death for patients with PA, VSD and MAPCAs.Further multi-centre analyses to establish the burden of this condition, subset comparative analyses of survivors vs non-survivors is likely to explain and help with appropriate treatment strategies in the future.
Zitieren
APA
He, Y., Li, Q., Zhang, C., & Gu, H. (2021). 2. “Treat-Close-Treat” strategy in adult congenital heart disease related pulmonary arterial hypertension (ACHD-PAH). International Journal of Cardiology Congenital Heart Disease. https://doi.org/10.1016/j.ijcchd.2020.100030
Vancouver
He Y, Li Q, Zhang C, Gu H. 2. “Treat-Close-Treat” strategy in adult congenital heart disease related pulmonary arterial hypertension (ACHD-PAH). International Journal of Cardiology Congenital Heart Disease. 2021. doi:10.1016/j.ijcchd.2020.100030
BibTeX
@article{He2021,
author = {He, Yuan and Li, Qiangqiang and Zhang, Chen and Gu, Hong},
title = {2. “Treat-Close-Treat” strategy in adult congenital heart disease related pulmonary arterial hypertension (ACHD-PAH)},
journal = {International Journal of Cardiology Congenital Heart Disease},
year = {2021},
doi = {10.1016/j.ijcchd.2020.100030}
}
EUVIMED